Abstract-The present study examined whether blockade of melanocortin receptors subtypes 3 and 4 (MC3/4-R) inhibits chronic cardiovascular and dietary responses to leptin infusion. A cannula was placed in the lateral ventricle of male Sprague-Dawley rats for chronic intracerebroventricular (ICV) infusion via osmotic minipump, and arterial and venous catheters were implanted for measurement of mean arterial pressure (MAP) and heart rate (HR) 24 h/d and IV infusions. After a 5-day control period, rats received (1) 0.9% saline vehicle ICV for 12 days plus leptin (1 g/kg per minute IV, nϭ5) during the final 7 days; (2) MC3/4-R antagonist SHU-9119 (1 nmol/h ICV) for 12 days plus leptin (1 g/kg per minute IV, nϭ6) during the final 7 days; and (3) SHU-9119 (1 nmol/h ICV, nϭ8) for 12 days. Leptin infusion in vehicle-treated rats caused a small increase in MAP (5Ϯ1 mm Hg) despite reduced food intake (23Ϯ1 to 10Ϯ1 g/d) and decreased body weight (Ϫ6%Ϯ1%). SHU-9119 infusion completely prevented the cardiovascular and dietary actions of leptin, leading to increased food intake (23Ϯ1 to 49Ϯ4 g/d) and body weight (ϩ30%Ϯ2%), markedly decreased HR (Ϫ77Ϯ9 bpm), and caused a decrease in MAP (Ϫ6Ϯ1 mm Hg). Similar results were observed when SHU-9119 was infused alone in vehicle-treated rats. Leptin decreased plasma insulin to 30% of control values, an effect that was also abolished by SHU-9119 treatment, which caused a 5-fold increase in plasma insulin concentration. Thus, MC3/4-R antagonism completely blocked the chronic cardiovascular, satiety, and metabolic effects of leptin, suggesting that the hypothalamic melanocortin system plays an important role in mediating these actions of leptin. Key Words: hypertension Ⅲ blood pressure Ⅲ obesity Ⅲ insulin L eptin is synthesized mainly by adipocytes in proportion to the amount of body fat, and has been shown to cause weight loss by reducing appetite and increasing energy expenditure by stimulating sympathetic nervous system (SNS) activity to various tissues, including brown adipose tissue. [1][2][3] Acute studies have also demonstrated that leptin increases SNS activity to the kidneys. 4 A previous study from our laboratory showed that chronic leptin infusions, producing levels similar to those observed in morbidly obese humans, caused sustained elevations in arterial pressure in rodents. 5 Moreover, the elevation in arterial pressure caused by chronic leptin infusion is prevented by combined ␣-and -adrenergic blockade. 6 This suggests that the adrenergic system mediates the chronic pressor actions of leptin and is consistent with the hypothesis that leptin may be an important factor linking obesity, increased SNS activity, and hypertension.The mechanisms that mediate the long-term actions of leptin on appetite, SNS activity, and blood pressure are still not fully understood, but may involve complex interactions with hypothalamic neuropeptide systems. Among these systems, the hypothalamic proopiomelanocortin (POMC) pathway may be especially important. One important POMC bioactive post-tr...